{
    "eid": "2-s2.0-85055135693",
    "title": "An early-biomarker algorithm predicts lethal graft-versus-host disease and survival",
    "cover-date": "2017-02-09",
    "subject-areas": [
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [],
    "authors": [
        "Matthew J. Hartwell"
    ],
    "citedby-count": 177,
    "ref-count": 36,
    "ref-list": [
        "Graft-versus-host disease",
        "Peripheral-blood stem cells versus bone marrow from unrelated donors",
        "Reduced mortality after allogeneic hematopoietic-cell transplantation",
        "Current Challenges in Chronic Graft-versus-Host Disease",
        "Advances in predicting acute GVHD",
        "Risk factors for acute GVHD and survival after hematopoietic cell transplantation",
        "Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial",
        "Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation",
        "Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective",
        "Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era",
        "A prognostic score for acute graft-versus-host disease based on biomarkers: A multicentre study",
        "A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality",
        "The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy",
        "Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation",
        "Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines",
        "Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease",
        "The IL-33/ST2 axis augments effector T-cell responses during acute GVHD",
        "ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease",
        "Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects",
        "Absence of \u03b27 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine",
        "Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction",
        "Up-Regulation of \u03b14\u03b27 Integrin on Peripheral T Cell Subsets Correlates with the Development of Acute Intestinal Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation",
        "Natalizumab for the Treatment of Active Crohn's Disease: Results of the ENCORE Trial",
        "Vedolizumab as induction and maintenance therapy for Crohn's disease",
        "Etrolizumab as induction therapy for ulcerative colitis: A randomised, controlled, phase 2 trial",
        "Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model",
        "Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality",
        "Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease",
        null,
        "Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration",
        "International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium",
        "ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death",
        "A biomarker panel for acute graft-versus-host disease",
        "A Proportional Hazards Model for the Subdistribution of a Competing Risk",
        "A New Look at the Statistical Model Identification",
        "Monte Carlo cross validation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nashville",
            "affilname": "Vanderbilt University Medical Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "affilname": "Icahn School of Medicine at Mount Sinai",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Wurzburg",
            "affilname": "Julius-Maximilians-Universit\u00e4t W\u00fcrzburg",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Dresden",
            "affilname": "Universit\u00e4tsklinikum Carl Gustav Carus Dresden",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Regensburg",
            "affilname": "Universit\u00e4t Regensburg",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Erlangen",
            "affilname": "Universit\u00e4tsklinikum Erlangen",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Boston",
            "affilname": "Massachusetts General Hospital",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "affilname": "Columbia University Irving Medical Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Ann Arbor",
            "affilname": "University of Michigan, Ann Arbor",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Salt Lake City",
            "affilname": "The University of Utah",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rome",
            "affilname": "IRCCS Ospedale Pediatrico Bambino Ges\u00f9",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Duarte",
            "affilname": "City of Hope National Med Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Philadelphia",
            "affilname": "University of Pennsylvania",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hamburg",
            "affilname": "Universit\u00e4tsklinikum Hamburg-Eppendorf",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Columbus",
            "affilname": "The Ohio State University",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Atlanta",
            "affilname": "Children's Healthcare of Atlanta",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "American Cancer Society",
        "National Cancer Institute",
        "National Cancer Institute",
        "Doris Duke Charitable Foundation",
        "National Center for Advancing Translational Sciences",
        "National Center for Advancing Translational Sciences"
    ]
}